We are live on ! Find out more
DMIIR

Drugs Made In America Acquisition II Corp Right
DMIIR

57 hedge funds and large institutions have $3.25M invested in Drugs Made In America Acquisition II Corp Right in 2026 Q1 according to their latest regulatory filings, with 14 funds opening new positions, 8 increasing their positions, 5 reducing their positions, and 4 closing their positions.

New
Increased
Maintained
Reduced
Closed

250% more first-time investments, than exits

New positions opened: 14 | Existing positions closed: 4

60% more repeat investments, than reductions

Existing positions increased: 8 | Existing positions reduced: 5

21% more funds holding

Funds holding: 47 → 57 (+10)

28% less capital invested

Capital invested by funds: $4.53M → $3.25M (-$1.28M)

Holders
57
Holders Change
+10
Holders Change %
+21.28%
% of All Funds
0.7%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
14
Increased
8
Reduced
5
Closed
4
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

Rank Fund Capital Flow
1
MI
MMCAP International
Cayman Islands
+$307K
2
Healthcare of Ontario Pension Plan (HOOPP) Trust Fund
Healthcare of Ontario Pension Plan (HOOPP) Trust Fund
Ontario, Canada
+$227K
3
Toronto Dominion Bank
Toronto Dominion Bank
Ontario, Canada
+$121K
4
HCM
Highbridge Capital Management
New York
+$104K
5
MCS
Mercuria Capital Strategies
Texas
+$85.2K

Top Sellers

Rank Fund Capital Flow
1
FTCM
First Trust Capital Management
Illinois
-$290K
2
Hudson Bay Capital Management
Hudson Bay Capital Management
Connecticut
-$30K
3
SCM
Shaolin Capital Management
Florida
-$17K
4
QL
Quarry LP
New York
-$11.3K
5
HCI
Harraden Circle Investments
New York
-$7K
Name Holding Trade Value Shares
Change 		Change in
Stake
MF
1
Magnetar Financial
Illinois
$216K – – –
MI
2
MMCAP International
Cayman Islands
$216K +$307K +2,700,000 New
Toronto Dominion Bank
3
Toronto Dominion Bank
Ontario, Canada
$216K +$121K +1,063,496 +65%
Millennium Management
4
Millennium Management
New York
$160K +$56.8K +500,000 +33%
Healthcare of Ontario Pension Plan (HOOPP) Trust Fund
5
Healthcare of Ontario Pension Plan (HOOPP) Trust Fund
Ontario, Canada
$160K +$227K +2,000,000 New
GCL
6
Glazer Capital LLC
New York
$152K – – –
Hudson Bay Capital Management
7
Hudson Bay Capital Management
Connecticut
$136K -$30K -263,680 -13%
PAMP
8
Polar Asset Management Partners
Ontario, Canada
$120K – – –
TCM
9
Tenor Capital Management
New York
$120K – – –
AC
10
Aristeia Capital
Connecticut
$108K +$28.4K +250,000 +23%
HIM
11
HGC Investment Management
Ontario, Canada
$98.5K – – –
AA
12
AQR Arbitrage
Connecticut
$92.7K +$834 +7,340 +0.6%
HCM
13
Highbridge Capital Management
New York
$89.1K +$104K +918,757 +91,601%
DKCM
14
Davidson Kempner Capital Management
New York
$80K – – –
D.E. Shaw & Co
15
D.E. Shaw & Co
New York
$80K – – –
OAC
16
OMERS Administration Corp
Ontario, Canada
$80K – – –
PMAM
17
Picton Mahoney Asset Management
Ontario, Canada
$70K – – –
CL
18
CSS LLC
Illinois
$64.5K – – –
LA
19
Linden Advisors
New York
$63.1K – – –
CCM
20
Context Capital Management
California
$60K – – –
GCM
21
Ghisallo Capital Management
Massachusetts
$60K – – –
MCM
22
Moore Capital Management
New York
$60K – – –
MCS
23
Mercuria Capital Strategies
Texas
$60K +$85.2K +750,000 New
RCM
24
Radcliffe Capital Management
Pennsylvania
$40.3K – – –
WAM
25
Wolverine Asset Management
Illinois
$40.2K -$227 -2,000 -0.4%
1
2 3

DMIIR Hedge Fund Activity: Q1 2026 in Review

57 of the 8,151 institutional investors tracked by Wall St. Rank reported a position in Drugs Made In America Acquisition II Corp Right (DMIIR) for Q1 2026, worth a combined $3.25M — down 28% from $4.53M a quarter earlier.

Buyers outnumbered sellers: 14 funds opened new DMIIR positions and 4 closed out — a net gain of 10 holders — while 8 added to existing stakes and 5 trimmed.

The largest buyer was MMCAP International, opening a new position worth an estimated $307K. The largest seller was First Trust Capital Management, exiting entirely with an estimated $290K sold.

  • 57 institutional investors held Drugs Made In America Acquisition II Corp Right (DMIIR) as of Q1 2026, up from 47 in Q4 2025.
  • Funds reported $3.25M of Drugs Made In America Acquisition II Corp Right stock for Q1 2026, down 28% quarter-over-quarter.
  • 14 funds opened new Drugs Made In America Acquisition II Corp Right positions in Q1 2026 and 4 closed out, a net change of +10 holders.
  • The largest Drugs Made In America Acquisition II Corp Right buyer in Q1 2026 was MMCAP International, an estimated $307K added.
  • The largest Drugs Made In America Acquisition II Corp Right seller in Q1 2026 was First Trust Capital Management, an estimated $290K sold.

Based on aggregated 13F filings for Q1 2026.